首页> 外文期刊>Parasitology Research >Antimalarial activity of betulinic acid and derivatives in vitro against Plasmodium falciparum and in vivo in P. berghei-infected mice.
【24h】

Antimalarial activity of betulinic acid and derivatives in vitro against Plasmodium falciparum and in vivo in P. berghei-infected mice.

机译:桦木酸及其衍生物体外抗恶性疟原虫的抗疟活性以及在伯氏疟原虫感染小鼠体内的抗疟活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Malaria is one of the most important tropical diseases and mainly affects populations living in developing countries. Reduced sensitivity of Plasmodium sp. to formerly recommended antimalarial drugs places an increasing burden on malaria control programs as well as on national health systems in endemic countries. The present study aims to evaluate the antimalarial activity of betulinic acid and its derivative compounds, betulonic acid, betulinic acid acetate, betulinic acid methyl ester, and betulinic acid methyl ester acetate. These substances showed antiplasmodial activity against chloroquine-resistant Plasmodium falciparum parasites in vitro, with IC(50) values of 9.89, 10.01, 5.99, 51.58, and 45.79 microM, respectively. Mice infected with Plasmodium berghei and treated with betulinic acid acetate had a dose-dependent reduction of parasitemia. Our results indicate that betulinic acid and its derivative compounds are candidates for the development of new antimalarial drugs.
机译:疟疾是最重要的热带疾病之一,主要影响发展中国家的人口。降低了疟原虫的敏感性。以前推荐的抗疟疾药物对疟疾控制计划以及流行国家的国家卫生系统造成了越来越大的负担。本研究旨在评估桦木酸及其衍生物,桦木酸,乙酸桦木酸,乙酸桦木酸甲酯和乙酸桦木酸甲酯的抗疟活性。这些物质在体外对耐氯喹的恶性疟原虫具有抗疟原虫活性,IC(50)值分别为9.89、10.01、5.99、51.58和45.79 microM。感染了伯氏疟原虫并用乙酸贝丁酸治疗的小鼠的寄生虫血症具有剂量依赖性的降低。我们的结果表明,桦木酸及其衍生物是开发新型抗疟药的候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号